Join now This is your opportunity to learn from experts and ask questions in real-time
But, Krumholz noted, the newer GLP-1 drugs, which are given as weekly injections instead of daily ones, have shown stronger benefits, especially for patients with obesity and those arent yet available as generics
Engs work sat largely dormant for nearly a decade, until animal studies around 1999 showed the lizard peptide improved glucose tolerance, expanded beta cell mass, and reduced food intake in rodents
This warning applies to all medications containing semaglutide, including Wegovy, as well as other GLP-1 agonists like Ozempic and Rybelsus, which are used for Type 2 diabetes (and off-label for weight loss)
doi:10.1016/j.celrep.2024.114501 28
Regulators have started to push back